These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22129796)

  • 1. Predictors of nonalcoholic steatohepatitis in obese children.
    Lerret SM; Garcia-Rodriguez L; Skelton J; Biank V; Kilway D; Telega G
    Gastroenterol Nurs; 2011; 34(6):434-7. PubMed ID: 22129796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
    Reha JL; Lee S; Hofmann LJ
    Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D; Boynton J; Lindor KD
    Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome.
    Setji TL; Holland ND; Sanders LL; Pereira KC; Diehl AM; Brown AJ
    J Clin Endocrinol Metab; 2006 May; 91(5):1741-7. PubMed ID: 16492691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.
    Lavine JE
    J Pediatr; 2000 Jun; 136(6):734-8. PubMed ID: 10839868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.
    Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA
    Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.
    Bedossa P; Poitou C; Veyrie N; Bouillot JL; Basdevant A; Paradis V; Tordjman J; Clement K
    Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic steatohepatitis in nondiabetic obese patients.
    Zamin I; de Mattos AA; Zettler CG
    Can J Gastroenterol; 2002 May; 16(5):303-7. PubMed ID: 12045779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
    Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
    Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase.
    Nadeau KJ; Klingensmith G; Zeitler P
    J Pediatr Gastroenterol Nutr; 2005 Jul; 41(1):94-8. PubMed ID: 15990637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients.
    Campos GM; Bambha K; Vittinghoff E; Rabl C; Posselt AM; Ciovica R; Tiwari U; Ferrel L; Pabst M; Bass NM; Merriman RB
    Hepatology; 2008 Jun; 47(6):1916-23. PubMed ID: 18433022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis.
    Muñoz LE; Cordero P; Torres L; Sauceda AY; Flores JP; Segura JJ
    Ann Hepatol; 2009; 8(2):123-8. PubMed ID: 19502655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men.
    Kim JK; Chon NR; Lim HC; Lee KS; Han KH; Chon CY; Park YN; Paik YH
    J Gastroenterol Hepatol; 2012 Jan; 27(1):142-8. PubMed ID: 21883454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated serum ALT in children presenting to the emergency unit: Relationship with NAFLD.
    Nobili V; Reale A; Alisi A; Morino G; Trenta I; Pisani M; Marcellini M; Raucci U
    Dig Liver Dis; 2009 Oct; 41(10):749-52. PubMed ID: 19362523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?
    Kazemi-Shirazi L; Veloso MP; Frommlet F; Steindl-Munda P; Wrba F; Zehetmayer S; Marsik C; Ferenci P
    Wien Klin Wochenschr; 2008; 120(1-2):25-30. PubMed ID: 18239988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.
    Cusi K; Sattar N; García-Pérez LE; Pavo I; Yu M; Robertson KE; Karanikas CA; Haupt A
    Diabet Med; 2018 Oct; 35(10):1434-1439. PubMed ID: 29869810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
    Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
    Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.